Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Research & Development In Brief: PPIs and B12 deficiency, multivitamins trim cataracts risk, vitamin E slows Alzheimer’s

This article was originally published in The Tan Sheet

Executive Summary

Heartburn medicines raise B12 deficiency risk; multivitamins reduce cataracts risk; fat-soluble vitamin E slows Alzheimer’s; and modified acetaminophen overdose treatment reduces adverse events.

You may also be interested in...

Extra Strength Tylenol Cap Warning Prompts Label Reading

Beginning in October, bottle caps of Extra Strength Tylenol will warn consumers the product contains acetaminophen and they should always read the label. The warning is the third element to highlight the ingredient on Extra Strength Tylenol but the redundancy may be necessary because consumers do not read labels.

J&J Consumer Sales Slip Even As Recalled Brands, Seasonal Items Reach Stores

J&J reports worldwide consumer sales dipped 0.6% to $3.6 billion despite retailers buying more upper respiratory and analgesic products to prepare for the cough and cold season. But in key OTC categories the firm is regaining market share it lost when its iconic brands were temporarily not available.

Ensuring Leading Position For GSK Consumer Products Touted In Management Shift

GlaxoSmithKline restructures its management to ensure adequate focus on its three core areas, pharmaceutical, vaccine and consumer. Consumer product sales fell 3% to $1.72 billion in the third quarter due to continuing supply interruptions and generally weaker markets.


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts